Physician profile
Robert C Grayson
NPI 1649234279
$1,949.61
in general payments reported to CMS, 2019-2025
20 companies · $253 in 2025
The $253 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $431 · 2020: $96.78 · 2021: $136 · 2022: $263 · 2023: $396 · 2024: $374 · 2025: $253.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,015 · Education: $8.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,014.66 |
| Education | $8.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $598.52 | 2019-2025 | |
| Organon LLC | $243.91 | 2021-2024 | Nexplanon |
| Mayne Pharma Commercial LLC | $164.98 | 2023-2025 | |
| Astellas Pharma US INC | $159.30 | 2023-2025 | Veozah |
| Coopersurgical, INC. | $143.43 | 2019-2024 | Paragard T 380a |
| Therapeuticsmd, INC. | $118.71 | 2019-2022 | |
| Millicent US INC | $67.38 | 2019-2024 | Femring, Intrarosa |
| Hologic Sales and Service, LLC | $64.20 | 2020-2025 | Aptima |
| Boston Scientific Corporation | $52.41 | 2019-2024 | |
| Myovant Sciences INC. | $51.47 | 2022 | |
| Pfizer INC. | $48.03 | 2021-2024 | |
| Allergan, INC. | $45.85 | 2019 | |
| Merck Sharp & Dohme LLC | $36.77 | 2019 | |
| Exeltis, USA INC. | $30.00 | 2025 | Slynd |
| Vertical Pharmaceuticals, LLC | $29.90 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Minerva Surgical, INC | $26.99 | 2019-2023 | |
| Olympus America INC. | $25.23 | 2023 | Visera 4k Uhd Camera Control Unit |
| Avion Pharmaceuticals | $14.73 | 2023 | Balcoltra |
| Myriad Women'S Health, INC. | $14.32 | 2023 | Myrisk |
| Bayer Healthcare Pharmaceuticals INC. | $13.48 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Grayson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.